EUVIMEDEUVIMED entdecken
Crossref

Impact of CFTR modulator therapy on basic life needs and financial concerns in people with cystic fibrosis: Data from the Well-ME survey

Heather Boas, Aricca D Van Citters, Elizabeth L Yu, Joel R King, Emily A Zagnit, Olivia Dieni, Clement L Ren

Journal of Cystic Fibrosis · 2025-07 · 24 (4) · 660-666

DOI: 10.1016/j.jcf.2025.01.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2025-07. Verfasst von Heather Boas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Sleep Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA; University of Pennsylvania Perelman School of M…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Chloride Channel Agonists. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Cystic Fibrosis Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: CFTR modulator (CFTR-M) therapy has led to improved clinical outcomes amongst people with cystic fibrosis (PwCF) eligible for these therapies. However, there is limited data on their impact on the basic life needs and financial concerns of PwCF. METHODS: We used data from the Wellness in the Modulator Era (Well-ME) survey, which includes data from 900 PwCF both taking and not taking CFTR-M. We examined self-reported financial well-being over time and changes associated with school or work, financial planning, and costs of living. Descriptive statistics were used to analyze responses. RESULTS: Most respondents reported no change in financial well-being, but 13 % identified a positive change and 16 % reported a negative change. Positive changes in basic life needs included fewer missed work and school days, while negative changes included medical out-of-pocket costs. Worries about financial problems were reported in 35 % of all respondents and were more common in PwCF who never took CFTR-M or had been taking one and then stopped, in PwCF with lower lung function, and in PwCF with Medicaid insurance. CONCLUSIONS: These results indicate that for most PwCF, CFTR-M have not affected their basic life needs, and a substantial proportion of PwCF continue to experience financial stress and concerns. Many respondents' financial concerns focused on medical costs and insurance. These data underscore the continued need for CF care teams to address PwCF's financial stress and ability to meet basic life needs, even in the era of improved physical health outcomes due to CFTR-M therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorChloride Channel AgonistsHumansMaleFemaleAdultUnited StatesSurveys and QuestionnairesCost of IllnessAdolescentHealth Expenditures

Stichwörter der Autor:innen

Cost of illnessDaily livingFinancial statusFinancial stressFinancial well-beingHealth costs

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorChloride Channel Agonists

Autor:innen und Institutionen

  • Division of Pulmonary and Sleep Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Electronic address: boash@chop.edu.
  • The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH 03756 USA.
  • Cystic Fibrosis Foundation, Bethesda, MD, USA.
  • Division of Pulmonary and Sleep Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Förderung

  • Cystic Fibrosis Foundation

Zitieren

APA

Boas, H., Van Citters, A. D., Yu, E. L., King, J. R., Zagnit, E. A., Dieni, O., & Ren, C. L. (2025). Impact of CFTR modulator therapy on basic life needs and financial concerns in people with cystic fibrosis: Data from the Well-ME survey. Journal of Cystic Fibrosis, 24(4), 660-666. https://doi.org/10.1016/j.jcf.2025.01.001

Vancouver

Boas H, Van Citters AD, Yu EL, King JR, Zagnit EA, Dieni O, et al. Impact of CFTR modulator therapy on basic life needs and financial concerns in people with cystic fibrosis: Data from the Well-ME survey. Journal of Cystic Fibrosis. 2025;24(4):660-666. doi:10.1016/j.jcf.2025.01.001

BibTeX
@article{Boas2025,
  author = {Boas, Heather and Van Citters, Aricca D and Yu, Elizabeth L and King, Joel R and Zagnit, Emily A and Dieni, Olivia and Ren, Clement L},
  title = {Impact of CFTR modulator therapy on basic life needs and financial concerns in people with cystic fibrosis: Data from the Well-ME survey},
  journal = {Journal of Cystic Fibrosis},
  year = {2025},
  volume = {24},
  number = {4},
  pages = {660--666},
  doi = {10.1016/j.jcf.2025.01.001}
}
Kostenlos starten →